HZNP — Horizon Therapeutics Share News
0.000.00%
Last trade - 00:00HealthcareBalancedLarge Cap
- $26.63bn
- $26.72bn
- $3.63bn
Horizon Therapeutics down as SLE drug fails mid-stage study
FTC chair called a 'disaster' as congressional hearing starts (updated)
Biden names two Republican nominees for FTC commissioner, White House says (updated)
Global mergers and acquisitions plunge in Q2 but dealmakers see green shoots (updated)
Brief: Horizon Therapeutics says Tepezza Approved In Brazil For Treatment Of Active Thyroid Eye Disease
Deals of the day-Mergers and acquisitions
California, other states join FTC bid to block Amgen deal (updated)
California, other states join FTC bid to block Amgen deal
U.S. RESEARCH ROUNDUP- Entegris, FedEx, Kellogg
Brief: Horizon Therapeutics Says Additional Data From Phase 4 Tepezza Clinical Trial Presented At The Endocrine Society Annual Meeting
Brief: Horizon Therapeutics plc Announces Partnership With KPMG Women’s Irish Open
Brief: Amgen Says On June 2, Court Issued An Order Granting Revised Stipulated TRO Proposed By Co, Horizon, FTC
US judge hearing fight over Amgen deal for Horizon eyes September trial (updated)
Judge hearing fight over Amgen deal for Horizon eyes September trial
Amgen agrees not to seek quick close to Horizon acquisition (updated)
Deals of the day-Mergers and acquisitions
Brief: Amgen Says Horizon, Co, FTC Submitted Stipulated Temporary Restraining Order To Court Providing Horizon, Co Would Not Close Deal Until Earlier Of Sept 15
U.S. court issues temporary restraining order on $27.8 bln Amgen-Horizon deal
FTC effort to stop Amgen's Horizon takeover faces uphill fight